Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
Jun 01, 2020
Braeburn Submits Request for Final Approval of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
Jan 10, 2020
Medicaid Expansion Associated with Fewer Total Opioid Overdose Deaths Across the U.S.
Jan 07, 2020
Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Medication-Assisted Treatment in Primary Care
Dec 23, 2019
Auburn's Harrison School of Pharmacy establishes Center for Opioid Research, Education and Outreach
Dec 19, 2019
Ascend Learning Clinical Healthcare and QURE Healthcare form training development partnership and launch primary care physician modules designed to improve CDC safe opioid prescribing guideline compliance
Dec 17, 2019
PTCB Funds Anti-Opioid Abuse Projects Including Naloxone Training for Pharmacy Technicians
Dec 02, 2019
New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes
Nov 25, 2019
Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence
Nov 19, 2019
Project Lifeline Community Partner, Researcher to be Honored at NACDS Foundation Dinner for Opioid Abuse Prevention Work
Oct 24, 2019
CVS Pharmacy to Offer Safe Medication Disposal Chain-Wide in 2020
Oct 23, 2019
Study reveals barriers to obtaining overdose-reversing drug naloxone in pharmacies, especially for teens
Oct 18, 2019
Global Opioid Overdose Pipeline Insights Report 2019
Oct 01, 2019
National Collaboration Needed to Combat Opioid Epidemic
Sep 26, 2019
Nura Pain Clinic to Provide Free Narcan Directly to Patients
Sep 25, 2019
Pharmacists Month and Day Invite Affirmation of Commitment to Opioid Abuse Prevention and Pain Care, NACDS Says
Sep 20, 2019
Statement from Acting FDA Commissioner Ned Sharpless, M.D., on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths
Sep 12, 2019
Comagine Health participates in study to reduce the risk of post-incarceration opioid overdose in women
Sep 10, 2019
Global Naloxone Spray Market Is Expected to Reach US$ 1,043.65 Million By 2027, Says Absolute Markets Insights
Aug 30, 2019
Center for Network Therapy Urges Making an Impact on International Overdose Awareness Day